Charan Shivpal Dan, Khilji Mohd Yunus, Jain Rashmi, Devra Vishal, Saxena Madhu
Department of Anaesthesiology, Sardar Patel Medical College, Bikaner, Rajasthan, India.
Anesth Essays Res. 2018 Jul-Sep;12(3):625-629. doi: 10.4103/aer.AER_65_18.
Postoperative sore throat (POST) occurs in 21%-65% of patients. Nebulization of ketamine reduces POST.
The aim of this study is to see the effectiveness of nebulized ketamine in different doses to reduce POST and observe adverse effects, if any.
This was a prospective, randomized, and double-blind controlled trial. One hundred and fifty patients of the American Society of Anesthesiologists physical status Classes I and II, in the age group of 18-60 years, of either sex, undergoing surgery under general anesthesia were randomized into three groups.
Patients had nebulized with 5 ml solution (Group K1 - 1 ml of ketamine [50 mg/ml] +4 ml normal saline, Group K2 - 0.5 ml of ketamine [50 mg/ml] +4.5 normal saline, and Group S - 5 ml normal saline). Preoperative, intraoperative, and postoperative hemodynamic monitoring was done. The POST monitoring was done at 2, 4, 8, 12, and 24 h postoperatively. POST was graded on a four-point scale (0-3).
Chi-square test using MSTAT software for POST and ANOVA test using INDOSTAT software for hemodynamics were used in this study.
The overall incidence of POST in the present study was 29.33% (44/150). In Group S, the incidence of POST was observed to be 46% (23/50). In Group K1, the incidence was 20% (10/50), and in Group K2, it was 22% (11/50) ( ≤ 0.05), and intraoperative vital signs were more stable at all time intervals.
We concluded that both doses (25 and 50 mg) of nebulized ketamine were almost equally effective in preventing POST, with no adverse effects.
术后咽痛(POST)在21% - 65%的患者中出现。氯胺酮雾化可减轻POST。
本研究旨在观察不同剂量氯胺酮雾化减轻POST的效果,并观察是否有不良反应。
这是一项前瞻性、随机、双盲对照试验。150例年龄在18 - 60岁、美国麻醉医师协会身体状况分级为I级和II级、接受全身麻醉手术的患者,不分性别,被随机分为三组。
患者用5毫升溶液进行雾化(K1组 - 1毫升氯胺酮[50毫克/毫升] + 4毫升生理盐水,K2组 - 0.5毫升氯胺酮[50毫克/毫升] + 4.5毫升生理盐水,S组 - 5毫升生理盐水)。进行术前、术中和术后血流动力学监测。术后2、4、8、12和24小时进行POST监测。POST按四点量表(0 - 3)分级。
本研究使用MSTAT软件进行POST的卡方检验,使用INDOSTAT软件进行血流动力学的方差分析。
本研究中POST的总体发生率为29.33%(44/150)。在S组中,POST发生率为46%(23/50)。在K1组中,发生率为20%(10/50),在K2组中为22%(11/50)(P≤0.05),且术中所有时间点生命体征更稳定。
我们得出结论,两种剂量(25毫克和50毫克)的氯胺酮雾化在预防POST方面几乎同样有效,且无不良反应。